processes described above results in substantially advantages over other known packaging processes in particular the use of sleeve 12 or cover 302 in conjunction with skin packaging greatly reduces the volume of package waste generated when an implant is consumed fewer components are required to package the implants and the implant can be packed in multiples sleeve 12 allows the end user to grasp the sterile implant firmly without contacting the implant surface instruments required to place the implant in a patient body can be attached while the implant is being held by sleeve 12 reducing the risk of premature contact with fluids in addition the skin package eliminates or at least minimizes motion within the packages 10 or 300 neither sleeve 12 nor cover 302 and pad 304 substantially compress the implant keeping the implant firmly positioned until opened by the end user moreover sleeve 12 or cover 302 and pad 304 protect implant coatings and surface finish from damage in turn skin pack lid 16 or 306 is protected from implant coatings and sharp features additionally sleeve 12 and cover 302 allow the end user to handle the implant without actually contacting the implant surface sleeve 12 and cover 302 also provide packages 10 or 300 with sleeker inner package profiles as compared with other implant packages further the skin packing process described above results in substantial cost savings since the presently disclosed skin packaging processes do not entail the use of foams the manufacturer may save time.